The rates of exosomal lncRNA PITPNA-AS1 positivity in SCLC, LUAD, or LUSC at stage III–IV were 65.5%, 71.0%, and 69.2%, respectively. This evidence concerns the gene PITPNA and small cell lung carcinoma.